סיטרבין להזרקה 1 גרם USP
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CYTARABINE 1 G/VIAL
Available from:
GENMEDIX
ATC code:
L01BC01
Pharmaceutical form:
POWDER FOR SOLUTION FOR INJECTION
Administration route:
I.V, S.C, INTRATRACHEAL
Manufactured by:
BEN VENUE LABORATORIES INC,USA
Therapeutic group:
CYTARABINE
Therapeutic indications:
Cytarabine in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphcytic leukemia of adults and children. It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. Intrathecal administration of cytarabine is indicated in the prophylaxis and treatment of meningeal leukemia.
Authorization date:
2008-12-01
